Publications by authors named "Matthew Masoli"

Claim this Profile
E
Effects of Obesity on Response to Asthma Biologic Treatment: Longitudinal Data From the United Kingdom Severe Asthma Registry.
Sherif Gonem, Charlene Redmond, John Busby, Pujan Patel, David J Jackson, Matthew Masoli

J Allergy Clin Immunol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study.
Joseph W Lanario, Drew Davies, Lucy Cartwright, Michael E Hyland, Matthew Masoli

PEC Innov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-biologic assessment of adherence in severe asthma and association with biologic continuation: a UK Severe Asthma Registry Study.
Freda Yang, Ronald McDowell, John Busby, Anna Claire Murphy, Pujan H Patel, Matthew Masoli

BMJ Open Respir Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Asthma Questionnaire (SAQ) and Asthma Control Questionnaire (ACQ) as Early Predictors of Biologic Response in Severe Asthma.
Drew Davies, Joseph W Lanario, Michael E Hyland, Matthew Masoli

J Asthma Allergy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma.
Ekaterina Khaleva, Chris Brightling, Thomas Eiwegger, Alan Altraja, Philippe Bégin, Matthew Masoli

Eur Respir J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving towards patient-centred outcomes: the Severe Asthma Questionnaire.
Drew Davies, Michael E Hyland, Joseph W Lanario, Rupert C Jones, Matthew Masoli

Eur Respir J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
Johannes A Kroes, Rafael Alfonso-Cristancho, Aruna T Bansal, Emmanuelle Berret, Kristina Bieksiene, Matthew Masoli

ERJ Open Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Life-changing": the experience of super-responders to biologics in severe asthma.
Joseph W Lanario, Lucy Cartwright, Rupert C Jones, Ross Sayers, Michael E Hyland, Matthew Masoli

BMC Pulm Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
Katrien Eger, Dora Paroczai, Alison Bacon, Florence Schleich, Svetlana Sergejeva, Matthew Masoli

ERJ Open Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?".
John W Upham, Chantal Le Lievre, David J Jackson, Matthew Masoli, Michael E Wechsler

J Allergy Clin Immunol Pract· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process.
John W Upham, Chantal Le Lievre, David J Jackson, Matthew Masoli, Michael E Wechsler

J Allergy Clin Immunol Pract· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma.
Michael E Hyland, Joseph W Lanario, Andrew Menzies-Gow, Adel H Mansur, James W Dodd, Matthew Masoli

Chron Respir Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma.
Giulio de Felice, Michael E Hyland, Joseph W Lanario, Yuri Antonacci, Rupert C Jones, Matthew Masoli

BMC Pulm Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference.
Matthew Masoli, Joseph W Lanario, Michael E Hyland, Andrew Menzies-Gow, Adel H Mansur

Eur Respir J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA).
Joseph W Lanario, Michael E Hyland, Andrew Menzies-Gow, Adel H Mansur, James W Dodd, Matthew Masoli

Health Qual Life Outcomes· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice.
Richard Beasley, James Harper, Matthew Masoli

Lancet Respir Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.
Joseph W Lanario, Michael E Hyland, Yinghui Wei, Rupert C Jones, Matthew Masoli

Respir Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia.
Michael E Hyland, Joseph W Lanario, Yinghui Wei, Rupert C Jones, Matthew Masoli

Immun Inflamm Dis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.
Sandhya Khurana, Guy G Brusselle, Elisabeth H Bel, J Mark FitzGerald, Matthew Masoli

Clin Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The construction and validation of the Severe Asthma Questionnaire.
Michael E Hyland, Rupert C Jones, Joseph W Lanario, Matthew Masoli

Eur Respir J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma.
Michael E Hyland, Joseph W Lanario, Jill Pooler, Matthew Masoli, Rupert C Jones

Health Qual Life Outcomes· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving quality of life relies on valid outcome measures as well as drugs.
Rupert C Jones, Matthew Masoli, Joseph W Lanario, Michael E Hyland

BMJ· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).
Robert M Niven, Dinesh Saralaya, Rekha Chaudhuri, Matthew Masoli, Ian Clifton

BMJ Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Difficult asthma": not as easy as you think.
Matthew Masoli

Chest· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales.
Michael E Hyland, Ben Whalley, Rupert C Jones, Matthew Masoli

Qual Life Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis